Home » Japan » Page 14

Japan

Committee of the Whole (Friday Morning and Afternoon) – Resolution L11. Removing stigma as a barrier to the availability and delivery of health, case and social services for people who use drugs

Canada: it’s not the first time I’ve seen this text. We’ve done a thorough analysis and we think this is worthy of showing the COW? ‘Alt PP13bis Acknowledging that removing stigmatising attitudes includes long term comprehensive multidisciplinary and balanced efforts by member states, in full conformity with the Universal Declaration of Human Rights, the Universal …

Read more

Plenary Session: Item 7. Follow-up to the special session of the General Assembly on the world drug problem held in 2016, including the seven thematic areas of the outcome document of the special session.

Chair: Member states committed to report timely on their progress in implementing the recommendations set out in the Outcome Document. The Commission held two rounds of discussion in 2016 and decided to continue holding such discussions; a third thematic discussion was held in 2017. Ambassador Moitinho de Almeida of Portugal: As CND facilitator for the …

Read more

Plenary Session: Item 6. Implementation of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem

Chair: Good morning please take your seats. We will now take up item 6 – Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem – Particularly B supply reduction and C countering money laundering Chief of organised crime and illicit trafficking branch with UNODC …

Read more

Plenary: Item 5. Implementation of the international drug control treaties (Wednesday 14th Morning Session)

(a) Changes in the scope of control of substances Secretary: For Item 5a on changing in the scope of control of substances proposed scheduling recommendations initiated by the WHO. It reflects comments from governments on factors related to recommendation initiated by the WHO. The Commision will examine recommendation on 12 substances as applicable to the …

Read more